UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration

Molecular and cellular neuroscience, 2019-10, Vol.100, p.103396-103396, Article 103396

2019

Volltextzugriff (PDF)

Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency

Nature (London), 2020-12, Vol.588 (7838), p.459-465

2020

Volltextzugriff (PDF)

Stages of pTDP-43 pathology in amyotrophic lateral sclerosis

Annals of neurology, 2013-07, Vol.74 (1), p.20-38

2013

Volltextzugriff (PDF)

RNA-binding proteins with prion-like domains in health and disease

Biochemical journal, 2017-04, Vol.474 (8), p.1417-1438

2017

Volltextzugriff (PDF)

RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy

Brain (London, England : 1878), 2019-12, Vol.142 (12), p.3753-3770

2019

Volltextzugriff (PDF)

TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response

PLoS genetics, 2019-05, Vol.15 (5), p.e1007947-e1007947

2019

Volltextzugriff (PDF)

TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy

Journal of neuropathology and experimental neurology, 2010-09, Vol.69 (9), p.918-929

2010

Volltextzugriff (PDF)

C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy

Science translational medicine, 2020-09, Vol.12 (559)

2020

Volltextzugriff (PDF)

TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia

Brain (London, England : 1878), 2016-11, Vol.139 (11), p.2983-2993

2016

Volltextzugriff (PDF)

The role of TDP-43 mislocalization in amyotrophic lateral sclerosis

Molecular neurodegeneration, 2020-08, Vol.15 (1), p.45-16, Article 45

2020

Volltextzugriff (PDF)

TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine approaches for patients with TDP-43 pathology

Drug discovery today, 2023-11, Vol.28 (11), p.103769-103769, Article 103769

2023

Volltextzugriff (PDF)

TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle

Nature (London), 2018-11, Vol.563 (7732), p.508-513

2018

Volltextzugriff (PDF)

Structural Transformation of the Amyloidogenic Core Region of TDP-43 Protein Initiates Its Aggregation and Cytoplasmic Inclusion

The Journal of biological chemistry, 2013-07, Vol.288 (27), p.19614-19624

2013

Volltextzugriff (PDF)

TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43

Neurobiology of disease, 2024-04, Vol.193, p.106437-106437, Article 106437

2024

Volltextzugriff (PDF)

Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins

Nature communications, 2023-10, Vol.14 (1), p.6492-6492, Article 6492

2023

Volltextzugriff (PDF)

Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy

Movement disorders, 2017-02, Vol.32 (2), p.246-255

2017

Volltextzugriff (PDF)

Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders

Human molecular genetics, 2013-10, Vol.22 (R1), p.R77-R87

2013

Volltextzugriff (PDF)

TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression

Nature communications, 2024-05, Vol.15 (1), p.4163-24, Article 4163

2024

Volltextzugriff (PDF)

Prevalence of transactive response DNA‐binding protein 43 (TDP‐43) proteinopathy in cognitively normal older adults: systematic review and meta‐analysis

Neuropathology and applied neurobiology, 2018-04, Vol.44 (3), p.286-297

2018

Volltextzugriff (PDF)

Limbic‐predominant age‐related TDP‐43 encephalopathy neuropathologic change and microvascular pathologies in community‐dwelling older persons

Brain pathology (Zurich, Switzerland), 2021-05, Vol.31 (3), p.e12939-n/a

2021

Volltextzugriff (PDF)

Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy

The Journal of neuroscience, 2016-07, Vol.36 (29), p.7707-7717

2016

Volltextzugriff (PDF)

Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A

Acta neuropathologica, 2015-01, Vol.129 (1), p.53-64

2015

Volltextzugriff (PDF)

TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes

Brain (London, England : 1878), 2015-10, Vol.138 (Pt 10), p.3110-3122

2015

Volltextzugriff (PDF)

Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology

eLife, 2021-06, Vol.10

2021

Volltextzugriff (PDF)

Transthyretin attenuates TDP-43 proteinopathy by autophagy activation via ATF4 in FTLD-TDP

Brain (London, England : 1878), 2023-05, Vol.146 (5), p.2089-2106

2023

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

ThemaDna-Binding Proteins - Metabolism

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(132)

Sprache

Englisch
(140)
Japanisch
(43)

Erscheinungsjahr

n.n

Thema

Science & Technology
(133)
Humans
(129)
Life Sciences & Biomedicine
(122)
Neurosciences & Neurology
(90)
Tdp-43 Proteinopathies - Pathology
(88)
Neurosciences
(87)
Pathology
(77)
Tdp-43 Proteinopathies - Metabolism
(72)
Animals
(66)
Amyotrophic Lateral Sclerosis
(65)
Clinical Neurology
(63)
Tdp-43
(63)
Dna-Binding Proteins - Genetics
(58)
Tdp-43 Proteinopathies - Genetics
(50)
Male
(48)
Brain - Pathology
(46)
Female
(46)
Neurodegeneration
(45)
Aged
(43)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration

Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency

Stages of pTDP-43 pathology in amyotrophic lateral sclerosis

RNA-binding proteins with prion-like domains in health and disease

RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy

TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response

TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy

C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy

TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia

The role of TDP-43 mislocalization in amyotrophic lateral sclerosis

TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine approaches for patients with TDP-43 pathology

TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle

Structural Transformation of the Amyloidogenic Core Region of TDP-43 Protein Initiates Its Aggregation and Cytoplasmic Inclusion

TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43

Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins

Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy

Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders

TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression

Prevalence of transactive response DNA‐binding protein 43 (TDP‐43) proteinopathy in cognitively normal older adults: systematic review and meta‐analysis

Limbic‐predominant age‐related TDP‐43 encephalopathy neuropathologic change and microvascular pathologies in community‐dwelling older persons

Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy

Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A

TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes

Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology

Transthyretin attenuates TDP-43 proteinopathy by autophagy activation via ATF4 in FTLD-TDP

Aktive Filter

Suchergebnisse filtern